AI assistant
Sun Pharmaceutical Industries Ltd. — Regulatory Filings 2024
Nov 26, 2024
59215_rns_2024-11-26_179b6a2f-09d4-484a-8d16-9803a74dd1d1.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
Sun Pharmaceutical Industries Limited Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai – 400 063, Maharashtra, INDIA. Tel.: (91-22) 4324 4324 Fax: (91-22) 4324 4343 Website: www.sunpharma.com Email: [email protected] CIN: L24230GJ1993PLC019050
==> picture [66 x 72] intentionally omitted <==
November 26, 2024
National Stock Exchange of India Limited Scrip Symbol: SUNPHARMA
BSE Limited Scrip Code: 524715
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Regulatory Order
This is to inform that the Company and its subsidiary, Sun Pharma Laboratories Limited, have received an order passed by statutory authority. Relevant details, as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, are provided in Annexure A .
The Company shall take appropriate action in the matter.
For Sun Pharmaceutical Industries Limited
Anoop Digitally signed by Anoop Anjanikumar Anjanikumar Deshpande Date: 2024.11.26 20:05:50 Deshpande +05'30' (Anoop Deshpande) Company Secretary and Compliance Officer ICSI Membership No.: A23983
Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA.
Reaching People. Touching Lives.
Sun Pharmaceutical Industries Limited Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai – 400 063, Maharashtra, INDIA. Tel.: (91-22) 4324 4324 Fax: (91-22) 4324 4343 Website: www.sunpharma.com Email: [email protected] CIN: L24230GJ1993PLC019050
==> picture [66 x 73] intentionally omitted <==
Annexure A
Disclosure under Para (A) of Part (A) of Schedule III to the Regulation 30 SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
| Sl.No. | Particulars | Information |
|---|---|---|
| a) | Name of the authority | Office of the Commissioner of Customs, (Imports),Mumbai |
| b) | Nature and details of theaction(s) taken, initiated, ororder(s) passed | Order passed under section 28(4), 125, 114A and 112(a)of the Customs Act, 1962, imposing redemption fine ofRs. 27,00,000/- and penalty of Rs. 1,25,85,588/- on theSun Pharmaceutical Industries Limited and imposingredemption fine of Rs. 9,00,00,000/- and penalty of Rs.47,89,41,968/- on Sun Pharma Laboratories Limited andpenalty of Rs. 25,00,000/- each on Mr. Nilesh Gandhi,SatishC. Jha andMr.RajeshWadhawa. |
| c) | Date of receipt of direction ororder, including any ad-interimor interim orders or any othercommunication from theauthority | November 26, 2024 |
| d) | Details of the violation(s)/contravention(s) Committed oralleged to be committed | Re-classification of imported products under HSN 1302(Extracts) to HSN 2106 (Food Supplement) –Recovery/Demand for differential duty amount byCustoms. |
| e) | Impact on financial, operation orother activities of the listedentity, quantifiable in monetaryterms to the extentpossible | There is no material impact on the Company's financial,operation or other activities. |
Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA.
Reaching People. Touching Lives.